Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
The Cost-Effectiveness of Bosentan in the United Kingdom for Patients with Pulmonary Arterial Hypertension of WHO Functional Class III
Value in Health, 06/26/09
Stevenson M et al. - Bosentan is likely to be a more cost-effective first-line therapy for patients with PAH FC III in the UK than no active intervention.
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
2009 earnings survey: How do you compare
Medical Economics, 09/29/09
Physician pay cuts on horizon at Michigan Blues
American Medical News , 10/19/09
Medicare cracks down on false claims
Medical Economics, 11/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


